Author:
Franz M.,Meyer T.,Gallhofer B.
Publisher
Springer Berlin Heidelberg
Reference55 articles.
1. Andreasen NC (1982) Negative Symptoms in Schizophrenia, Definition and Reliability. Arch Gen Psychiat 39: 784–788
2. Angermeyer MC, Katschnig H (1997) Psychotropic medication and quality of life: a conceptual framework for assessing their relationsships. In: H Katschnig, H Freeman, N Sartorius (eds) Quality of life in mental disorders. Wiley, Chichester, pp 215–225
3. Awad GA, Lapierre YD, Angus C, Rylander A (1997) Quality of life and response of negative symptoms in schizophrenia to Haloperidol and the atypical antipsychotic Remoxipride. J Psychiatry Neurosci 22 (4): 244–248
4. Awad AG, Voruganti LNP, Heslegrave RJ, Hogan TP (1996) Assessment of the patient’s subjective experience in acute neuroleptic treatment: implications for compliance and outcome. International Clinical Psychopharmacology 11 (Suppl 2): 55–59
5. Barnes TRE, McPhillips MA (1995) How to distinguish between the neuroleptic-induced deficit syndrome, depression and disease-related negative symptoms in schizophrenia. International Clinical Psychopharmacology 10 (Suppl 3): 115–121